News from the MCRC
Impact Case Study
PROCAS and BC-PREDICT
We speak to Professor Gareth Evans about how the findings from PROCAS 1 led to the inception of PROCAS 2, which assesses the feasibility of implementing a personalised risk score into a woman’s first screening appointment and the associated impact on NHS staff, patients and other related organisations.
Partner News
10/05/2022
Indoor tanning ban would reduce melanoma deaths, show researchers
Director's Update
05/05/2022
MCRC Director’s Update – April 2022
April 2022 sees us officially launch the new vision of the Cancer Research UK Manchester Centre and our aim of driving translational research from the lab to the clinic.
Director's Update
25/03/2022
MCRC Director’s Update – March 2022
Director's Update
25/03/2022
On Cancer Westminster Launch
On 3 March 2022, to mark the launch of On Cancer, Policy@Manchester organised a panel discussion in Westminster to spotlight the policy recommendations that could help improve the lives of patients impacted by cancer.
MCRC Blog
24/03/2022
The ALETHEIA framework in radiation oncology
MCRC Blog
16/03/2022
MCRC-DCS Alumni Showcase
Manchester Cancer Research Centre and Division of Cancer Sciences clinical and non-clinical PhD alumni discuss their post-PhD career highlights and tips for current postgraduate researchers.
Partner News
14/03/2022
New era for Kenyan healthcare begins
Director's Update
04/03/2022
MCRC Director’s Update – February 2022
TARGET National, Stampede, and DETERMINE clinical trials, as well as activities from World Cancer Day and Equality Diversity and Inclusivity cap off February at the MCRC.
Researcher Stories
02/03/2022
Thomas Kedward
Director's Update
04/02/2022
Introducing On Cancer
Professor Rob Bristow outlines the importance of the On Cancer publication and engagement of policy makers alongside our unique research and technologies here in Manchester.
Researcher Stories
17/01/2022
Hadiyat Ogunlayi
Research Spotlight
05/01/2022
Cancer researchers across the UK join forces to find drugs for rare cancers
DETERMINE is the first UK national precision medicine trial in rare cancers, testing a range of therapies specifically targeting key genetic changes in cancer cells.
MCRC Blog
17/12/2021
Cancer Revolution: Science, Innovation and Hope
Our blog covering the SIM exhibition, Cancer Revolution: Science, Innovation and Hope, which spotlights the pioneering work of our researchers here at the MCRC.
